BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹1.55 Cr | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr | ₹3.58 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹1.55 Cr |
Mar2023 | ₹0.70 Cr |
Mar2022 | ₹0.60 Cr |
Mar2021 | ₹2.63 Cr |
Mar2020 | ₹3.58 Cr |
How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.55 Cr | 120.34 | |
Mar2023 | ₹0.70 Cr | 16.39 | |
Mar2022 | ₹0.60 Cr | -77.05 | |
Mar2021 | ₹2.63 Cr | -26.56 | |
Mar2020 | ₹3.58 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹147.1 Cr | -1.6% | -5.2% | -22.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹389,172.0 Cr | -1.2% | -3.6% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,248.0 Cr | -6.6% | -12.4% | 22.3% | Stock Analytics | |
CIPLA | ₹122,835.0 Cr | 0.3% | 1.2% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 0.7% | 9.1% | 7.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,869.0 Cr | 0.4% | -2.8% | -12.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -1.6% |
-5.2% |
-22.3% |
SENSEX | -0.6% |
-2.8% |
1.7% |
You may also like the below Video Courses